BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34333327)

  • 21. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
    Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
    Pacheco-Velázquez SC; Robledo-Cadena DX; Hernández-Reséndiz I; Gallardo-Pérez JC; Moreno-Sánchez R; Rodríguez-Enríquez S
    Mol Pharm; 2018 Jun; 15(6):2151-2164. PubMed ID: 29746779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PGC-1α activates SIRT3 to modulate cell proliferation and glycolytic metabolism in breast cancer.
    Zu Y; Chen XF; Li Q; Zhang ST; Si LN
    Neoplasma; 2021 Mar; 68(2):352-361. PubMed ID: 33231084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
    Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
    PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo.
    Zhao Y; Jing Z; Lv J; Zhang Z; Lin J; Cao X; Zhao Z; Liu P; Mao W
    Biomed Pharmacother; 2017 Nov; 95():18-24. PubMed ID: 28826092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
    Natarajan S; Ranganathan M
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
    Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
    Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of ROS production, autophagy or apoptosis signaling reversed the anticancer properties of Antrodia salmonea in triple-negative breast cancer (MDA-MB-231) cells.
    Chang CT; Korivi M; Huang HC; Thiyagarajan V; Lin KY; Huang PJ; Liu JY; Hseu YC; Yang HL
    Food Chem Toxicol; 2017 May; 103():1-17. PubMed ID: 28219700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-breast cancer property of physcion via oxidative stress-mediated mitochondrial apoptosis and immune response.
    Zhang L; Dong R; Wang Y; Wang L; Zhou T; Jia D; Meng Z
    Pharm Biol; 2021 Dec; 59(1):303-310. PubMed ID: 33715588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor.
    Sarwar M; Syed Khaja AS; Aleskandarany M; Karlsson R; Althobiti M; Ødum N; Mongan NP; Dizeyi N; Johnson H; Green AR; Ellis IO; Rakha EA; Persson JL
    Oncogene; 2019 Jan; 38(3):375-389. PubMed ID: 30104711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers.
    Arora R; Schmitt D; Karanam B; Tan M; Yates C; Dean-Colomb W
    Oncotarget; 2015 Jan; 6(2):662-78. PubMed ID: 25575825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of FBI-1 silencing on proliferation and apoptosis of triple-negative breast cancer cell line MDA-MB-231].
    Chen MJ; Wang L; Yang WP; Qin QH; Tan QX; Lian B; Wei CY
    Sheng Li Xue Bao; 2018 Oct; 70(5):497-503. PubMed ID: 30377688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-deoxy-D-glucose augments photodynamic therapy induced mitochondrial caspase-independent apoptosis and energy-mediated autophagy.
    Feng X; Shi Y; Xie L; Zhang K; Wang X; Liu Q; Wang P
    Lasers Surg Med; 2019 Apr; 51(4):352-362. PubMed ID: 30277589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
    Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
    J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression.
    Moradi M; Gholipour H; Sepehri H; Attari F; Delphi L; Arefian E; Moridi Farimani M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2145-2156. PubMed ID: 32617603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
    PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
    Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
    Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.